Document detail
ID

doi:10.1007/s10461-024-04294-2...

Author
Evangeli, Michael Gnan, Georgina Musiime, Victor Fidler, Sarah Seeley, Janet Frize, Graham Uwizera, Annette Lisi, Matteo Foster, Caroline
Langue
en
Editor

Springer

Category

Medicine & Public Health

Year

2024

listing date

3/20/2024

Keywords
hiv disclosure perinatal feasibility intervention adults study feasibility p = 0 follow-up pah participants hiv uk uganda intervention
Metrics

Abstract

Young adults with perinatally acquired HIV (PAH) face numerous challenges, including antiretroviral therapy (ART) adherence, managing onward HIV transmission risks and maintaining wellbeing.

Sharing one’s HIV status with others (onward HIV disclosure) may assist with these challenges but this is difficult.

We developed and tested the feasibility of an intervention to help HIV status sharing decision-making for young adults with PAH.

The study used a randomised parallel group feasibility design with 18–25-year-olds in Uganda and 18–29 year-olds in the UK.

Participants were randomly assigned to intervention or standard of care (SOC) condition.

The intervention consisted of four sessions (3 group, 1 individual) with follow-up support, delivered in person in Uganda and remotely in the UK.

Assessments were carried out at: Pre-intervention /baseline; Post-intervention (intervention group only); Six-month follow-up.

142 participants were recruited (94 Uganda, 48 UK; 89 female, 53 male).

At six-month follow-up, 92/94 (98%) participants were retained in Uganda, 25/48 (52%) in the UK.

Multivariate analysis of combined data from both countries, showed a non-significant effect of intervention condition on HIV disclosure cognitions and affect (p = 0.08) and HIV disclosure intention (p = 0.09).

There was a significant intervention effect on well-being (p = 0.005).

This study addressed important gaps in understanding acceptable and feasible ways of delivering HIV status sharing support for young people living with PAH across two very different settings.

The intervention was acceptable in both countries and feasible in Uganda.

In the UK, retention may have been affected by its remote delivery.

Trial registration: ISRCTN Registry, ISRCTN31852047, Registered on 21 January 2019.

Evangeli, Michael,Gnan, Georgina,Musiime, Victor,Fidler, Sarah,Seeley, Janet,Frize, Graham,Uwizera, Annette,Lisi, Matteo,Foster, Caroline, 2024, The HIV Empowering Adults’ Decisions to Share: UK/Uganda (HEADS-UP) Study—A Randomised Feasibility Trial of an HIV Disclosure Intervention for Young Adults with Perinatally Acquired HIV, Springer

Document

Open

Share

Source

Articles recommended by ES/IODE AI

Exploration of the influence of GOLGA8B on prostate cancer progression and the resistance of castration-resistant prostate cancer to cabazitaxel
castration-resistant prostate canc... ... cabazitaxel cancer development expression genes influence crpc resistance golga8b pca prostate cancer cabazitaxel